We've found
3,657 Endocrine
clinical trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology Clinical Trial
Determination of the Independent Effects of Beetroot Juice Components, Dietary Nitrate and Antioxidants, on Exercise Tolerance and Health Benefits in Individuals With Obesity
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology Clinical Trial
Amitriptyline in Treating Hypoglycemia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Nephrology / Urology, Other Clinical Trial
Safety, Efficacy, PK and PD of CTAP101 (Calcifediol) ER Capsules for SHPT in HD Patients VDI
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Immunology / Infectious Diseases Clinical Trial
Cardiometabolic Benefits of Potatoes Mediated Along the Gut-Vessel Axis in Adults With Metabolic Syndrome
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Adaptive Tyrosine Kinase Inhibitor (TKI) Therapy In Patients With Thyroid Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology Clinical Trial
Novel Approach for the Prevention of Hypoglycemia Associated Autonomic Failure (HAAF)
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology Clinical Trial
WALK Study: Women's Active Living for Koreans Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology Clinical Trial
Open-label Treatment in Cushing's Syndrome
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology Clinical Trial
Open-label Treatment in Cushing's Syndrome
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology Clinical Trial
Open-label Treatment in Cushing's Syndrome
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hypoparathyroidism Clinical Trial
Study of the Effect of Recombinant Human Parathyroid Hormone [rhPTH(1-84)] on Symptoms Improvement and Metabolic Control Among Adults With Hypoparathyroidism
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Hypoparathyroidism Clinical Trial
Study of the Effect of Recombinant Human Parathyroid Hormone [rhPTH(1-84)] on Symptoms Improvement and Metabolic Control Among Adults With Hypoparathyroidism
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Type 1 Diabetes Mellitus Clinical Trial
Safety and Feasibility of an Insulin Sensitivity-Informed Bolus Calculator in Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Glucose Metabolism Disorders Clinical Trial
Effects of Deepure(Pu-erh Tea Extract) on Glycemic Control
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Metabolic Syndrome X Clinical Trial
Mechanisms of Cerebrovascular Control
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Hematology, Nephrology / Urology, Pulmonary / Respiratory Diseases, Reproductive Clinical Trial
Collection of Samples From Pregnant Women for the Evaluation of Preeclampsia (Pre-E) Biomarkers
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Hematology, Nephrology / Urology, Pulmonary / Respiratory Diseases, Reproductive Clinical Trial
Collection of Samples From Pregnant Women for the Evaluation of Preeclampsia (Pre-E) Biomarkers
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Hematology, Nephrology / Urology, Neurology, Ophthalmology, Pulmonary / Respiratory Diseases, Reproductive Clinical Trial
Collection of Whole Blood Samples for the Evaluation of Preeclampsia (Pre-E) Biomarkers From Pregnant Women
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Hematology, Nephrology / Urology, Neurology, Ophthalmology, Pulmonary / Respiratory Diseases, Reproductive Clinical Trial
Collection of Whole Blood Samples for the Evaluation of Preeclampsia (Pre-E) Biomarkers From Pregnant Women
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Hematology, Nephrology / Urology, Neurology, Ophthalmology, Pulmonary / Respiratory Diseases, Reproductive Clinical Trial
Collection of Whole Blood Samples for the Evaluation of Preeclampsia (Pre-E) Biomarkers From Pregnant Women
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Personalized Treatment in Thyroid Disorders
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Hematology, Immunology / Infectious Diseases Clinical Trial
Evaluation of MyoStrain™ in Clinical Practice
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Celiac Disease Clinical Trial
Study of the Safety, Pharmacodynamics, Efficacy, and PK of TIMP-GLIA in Subjects With Celiac Disease
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Celiac Disease Clinical Trial
Study of the Safety, Pharmacodynamics, Efficacy, and PK of TIMP-GLIA in Subjects With Celiac Disease
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Phenylketonurias Clinical Trial
Nutrition Status of Adults Treated With Pegvaliase
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Clinical Trial
Use of a Hyperinsulinemic-hypyglycemic Clamp to Study Hypoglycemia: a Method Development Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Association Between Cancer and Sarcoidosis
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrine Disease Clinical Trial
Study of Endocrine-Related Conditions and Physiology
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Oncology, Other Clinical Trial
Studies of Elevated Parathyroid Activity
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Autoimmune Lymphproliferative Syndrome Clinical Trial
Study of Autoimmune Lymphoproliferative Syndrome (ALPS)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Randall's Plaque Study: Pathogenesis and Relationship to Nephrolithiasis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Immunology / Infectious Diseases Clinical Trial
Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Mucopolysaccharidosis VI (MPS VI, Maroteaux-Lamy Syndrome) Clinical Trial
Mucopolysaccharidosis (MPS) VI Clinical Surveillance Program (CSP)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Mucopolysaccharidosis VI (MPS VI, Maroteaux-Lamy Syndrome) Clinical Trial
Mucopolysaccharidosis (MPS) VI Clinical Surveillance Program (CSP)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Mucopolysaccharidosis VI (MPS VI, Maroteaux-Lamy Syndrome) Clinical Trial
Mucopolysaccharidosis (MPS) VI Clinical Surveillance Program (CSP)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Mucopolysaccharidosis VI (MPS VI, Maroteaux-Lamy Syndrome) Clinical Trial
Mucopolysaccharidosis (MPS) VI Clinical Surveillance Program (CSP)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Mucopolysaccharidosis VI (MPS VI, Maroteaux-Lamy Syndrome) Clinical Trial
Mucopolysaccharidosis (MPS) VI Clinical Surveillance Program (CSP)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Neurology, Other Clinical Trial
Longitudinal Study of Urea Cycle Disorders
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Neurology, Other Clinical Trial
Longitudinal Study of Urea Cycle Disorders
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Neurology, Other Clinical Trial
Longitudinal Study of Urea Cycle Disorders
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Neurology, Other Clinical Trial
Longitudinal Study of Urea Cycle Disorders
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Neurology, Other Clinical Trial
Longitudinal Study of Urea Cycle Disorders
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
The Effect of Diet and Exercise in Heart Failure
Status: Enrolling
Updated: 12/2/2010
Click here to add this to my saved trials
Endocrinology Clinical Trial
Examination of Idiopathic Hypogonadotropic Hypogonadism (IHH)and Kallmann Syndrome (KS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Reproductive Clinical Trial
Baselines in Reproductive Disorders
Status: Enrolling
Updated: 7/31/2014
Click here to add this to my saved trials
Endocrinology, Pulmonary / Respiratory Diseases Clinical Trial
A Study of the Natural Progression of Interstitial Lung Disease (ILD)
Status: Enrolling,
Phase
Updated: 4/26/2018
Click here to add this to my saved trials
Endocrinology, Other Clinical Trial
Investigation of the Genetic Causes of Kallmann Syndrome and Reproductive Disorders
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endometrial Cancer Clinical Trial
Study of Insulin Resistance and Endometrial Cancer in Harris County, Texas
Status: Enrolling
Updated: 5/2/2013
Click here to add this to my saved trials
Endometrial Cancer Clinical Trial
Study of Insulin Resistance and Endometrial Cancer in Harris County, Texas
Status: Enrolling
Updated: 5/2/2013
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Phase II Trial of Sorafenib (Nexavar) in Patients With Advanced Thyroid Cancer
Status: Enrolling,
Phase
II
Updated: 4/1/2008
Click here to add this to my saved trials
Autoimmune Disease Clinical Trial
Carmustine, Etoposide, Cytarabine, Melphalan, and Antithymocyte Globulin Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Autoimmune Neurologic Disease That Did Not Respond to Previous Therapy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Kawasaki Disease Clinical Trial
Infliximab Plus Intravenous Immunoglobulin for the Primary Treatment of Kawasaki Disease
Status: Enrolling
Updated: 4/7/2011
Click here to add this to my saved trials
Endocrinology Clinical Trial
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology Clinical Trial
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology Clinical Trial
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology Clinical Trial
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology Clinical Trial
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology Clinical Trial
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology Clinical Trial
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
We've found
3,657 Endocrine
clinical trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology Clinical Trial
Updated: 12/31/1969
Determination of the Independent Effects of Beetroot Juice Components, Dietary Nitrate and Antioxidants, on Exercise Tolerance and Health Benefits in Individuals With Obesity
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology Clinical Trial
Updated: 12/31/1969
Amitriptyline in Treating Hypoglycemia
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Nephrology / Urology, Other Clinical Trial
Updated: 12/31/1969
Safety, Efficacy, PK and PD of CTAP101 (Calcifediol) ER Capsules for SHPT in HD Patients VDI
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
Cardiometabolic Benefits of Potatoes Mediated Along the Gut-Vessel Axis in Adults With Metabolic Syndrome
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Adaptive Tyrosine Kinase Inhibitor (TKI) Therapy In Patients With Thyroid Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology Clinical Trial
Updated: 12/31/1969
Novel Approach for the Prevention of Hypoglycemia Associated Autonomic Failure (HAAF)
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology Clinical Trial
Updated: 12/31/1969
WALK Study: Women's Active Living for Koreans Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology Clinical Trial
Updated: 12/31/1969
Open-label Treatment in Cushing's Syndrome
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology Clinical Trial
Updated: 12/31/1969
Open-label Treatment in Cushing's Syndrome
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology Clinical Trial
Updated: 12/31/1969
Open-label Treatment in Cushing's Syndrome
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hypoparathyroidism Clinical Trial
Updated: 12/31/1969
Study of the Effect of Recombinant Human Parathyroid Hormone [rhPTH(1-84)] on Symptoms Improvement and Metabolic Control Among Adults With Hypoparathyroidism
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Hypoparathyroidism Clinical Trial
Updated: 12/31/1969
Study of the Effect of Recombinant Human Parathyroid Hormone [rhPTH(1-84)] on Symptoms Improvement and Metabolic Control Among Adults With Hypoparathyroidism
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Type 1 Diabetes Mellitus Clinical Trial
Updated: 12/31/1969
Safety and Feasibility of an Insulin Sensitivity-Informed Bolus Calculator in Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Glucose Metabolism Disorders Clinical Trial
Updated: 12/31/1969
Effects of Deepure(Pu-erh Tea Extract) on Glycemic Control
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Metabolic Syndrome X Clinical Trial
Updated: 12/31/1969
Mechanisms of Cerebrovascular Control
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Hematology, Nephrology / Urology, Pulmonary / Respiratory Diseases, Reproductive Clinical Trial
Updated: 12/31/1969
Collection of Samples From Pregnant Women for the Evaluation of Preeclampsia (Pre-E) Biomarkers
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Hematology, Nephrology / Urology, Pulmonary / Respiratory Diseases, Reproductive Clinical Trial
Updated: 12/31/1969
Collection of Samples From Pregnant Women for the Evaluation of Preeclampsia (Pre-E) Biomarkers
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Hematology, Nephrology / Urology, Neurology, Ophthalmology, Pulmonary / Respiratory Diseases, Reproductive Clinical Trial
Updated: 12/31/1969
Collection of Whole Blood Samples for the Evaluation of Preeclampsia (Pre-E) Biomarkers From Pregnant Women
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Hematology, Nephrology / Urology, Neurology, Ophthalmology, Pulmonary / Respiratory Diseases, Reproductive Clinical Trial
Updated: 12/31/1969
Collection of Whole Blood Samples for the Evaluation of Preeclampsia (Pre-E) Biomarkers From Pregnant Women
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Hematology, Nephrology / Urology, Neurology, Ophthalmology, Pulmonary / Respiratory Diseases, Reproductive Clinical Trial
Updated: 12/31/1969
Collection of Whole Blood Samples for the Evaluation of Preeclampsia (Pre-E) Biomarkers From Pregnant Women
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Personalized Treatment in Thyroid Disorders
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Hematology, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
Evaluation of MyoStrain™ in Clinical Practice
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Celiac Disease Clinical Trial
Updated: 12/31/1969
Study of the Safety, Pharmacodynamics, Efficacy, and PK of TIMP-GLIA in Subjects With Celiac Disease
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Celiac Disease Clinical Trial
Updated: 12/31/1969
Study of the Safety, Pharmacodynamics, Efficacy, and PK of TIMP-GLIA in Subjects With Celiac Disease
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Phenylketonurias Clinical Trial
Updated: 12/31/1969
Nutrition Status of Adults Treated With Pegvaliase
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Clinical Trial
Updated: 12/31/1969
Use of a Hyperinsulinemic-hypyglycemic Clamp to Study Hypoglycemia: a Method Development Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Updated: 12/31/1969
Association Between Cancer and Sarcoidosis
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrine Disease Clinical Trial
Updated: 12/31/1969
Study of Endocrine-Related Conditions and Physiology
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Oncology, Other Clinical Trial
Updated: 12/31/1969
Studies of Elevated Parathyroid Activity
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Autoimmune Lymphproliferative Syndrome Clinical Trial
Updated: 12/31/1969
Study of Autoimmune Lymphoproliferative Syndrome (ALPS)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Updated: 12/31/1969
Randall's Plaque Study: Pathogenesis and Relationship to Nephrolithiasis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Mucopolysaccharidosis VI (MPS VI, Maroteaux-Lamy Syndrome) Clinical Trial
Updated: 12/31/1969
Mucopolysaccharidosis (MPS) VI Clinical Surveillance Program (CSP)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Mucopolysaccharidosis VI (MPS VI, Maroteaux-Lamy Syndrome) Clinical Trial
Updated: 12/31/1969
Mucopolysaccharidosis (MPS) VI Clinical Surveillance Program (CSP)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Mucopolysaccharidosis VI (MPS VI, Maroteaux-Lamy Syndrome) Clinical Trial
Updated: 12/31/1969
Mucopolysaccharidosis (MPS) VI Clinical Surveillance Program (CSP)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Mucopolysaccharidosis VI (MPS VI, Maroteaux-Lamy Syndrome) Clinical Trial
Updated: 12/31/1969
Mucopolysaccharidosis (MPS) VI Clinical Surveillance Program (CSP)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Mucopolysaccharidosis VI (MPS VI, Maroteaux-Lamy Syndrome) Clinical Trial
Updated: 12/31/1969
Mucopolysaccharidosis (MPS) VI Clinical Surveillance Program (CSP)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Neurology, Other Clinical Trial
Updated: 12/31/1969
Longitudinal Study of Urea Cycle Disorders
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Neurology, Other Clinical Trial
Updated: 12/31/1969
Longitudinal Study of Urea Cycle Disorders
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Neurology, Other Clinical Trial
Updated: 12/31/1969
Longitudinal Study of Urea Cycle Disorders
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Neurology, Other Clinical Trial
Updated: 12/31/1969
Longitudinal Study of Urea Cycle Disorders
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Neurology, Other Clinical Trial
Updated: 12/31/1969
Longitudinal Study of Urea Cycle Disorders
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Updated: 12/2/2010
The Effect of Diet and Exercise in Heart Failure
Status: Enrolling
Updated: 12/2/2010
Click here to add this to my saved trials
Endocrinology Clinical Trial
Updated: 12/31/1969
Examination of Idiopathic Hypogonadotropic Hypogonadism (IHH)and Kallmann Syndrome (KS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Reproductive Clinical Trial
Updated: 7/31/2014
Baselines in Reproductive Disorders
Status: Enrolling
Updated: 7/31/2014
Click here to add this to my saved trials
Endocrinology, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 4/26/2018
A Study of the Natural Progression of Interstitial Lung Disease (ILD)
Status: Enrolling,
Phase
Updated: 4/26/2018
Click here to add this to my saved trials
Endocrinology, Other Clinical Trial
Updated: 12/31/1969
Investigation of the Genetic Causes of Kallmann Syndrome and Reproductive Disorders
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endometrial Cancer Clinical Trial
Updated: 5/2/2013
Study of Insulin Resistance and Endometrial Cancer in Harris County, Texas
Status: Enrolling
Updated: 5/2/2013
Click here to add this to my saved trials
Endometrial Cancer Clinical Trial
Updated: 5/2/2013
Study of Insulin Resistance and Endometrial Cancer in Harris County, Texas
Status: Enrolling
Updated: 5/2/2013
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Updated: 4/1/2008
Phase II Trial of Sorafenib (Nexavar) in Patients With Advanced Thyroid Cancer
Status: Enrolling,
Phase
II
Updated: 4/1/2008
Click here to add this to my saved trials
Autoimmune Disease Clinical Trial
Updated: 12/31/1969
Carmustine, Etoposide, Cytarabine, Melphalan, and Antithymocyte Globulin Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Autoimmune Neurologic Disease That Did Not Respond to Previous Therapy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Kawasaki Disease Clinical Trial
Updated: 4/7/2011
Infliximab Plus Intravenous Immunoglobulin for the Primary Treatment of Kawasaki Disease
Status: Enrolling
Updated: 4/7/2011
Click here to add this to my saved trials
Endocrinology Clinical Trial
Updated: 12/31/1969
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology Clinical Trial
Updated: 12/31/1969
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology Clinical Trial
Updated: 12/31/1969
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology Clinical Trial
Updated: 12/31/1969
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology Clinical Trial
Updated: 12/31/1969
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology Clinical Trial
Updated: 12/31/1969
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology Clinical Trial
Updated: 12/31/1969
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials